The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer

[1]  A. Mokdad,et al.  Predictors of Early Mortality in Veteran Patients With Pancreatic Cancer: 21 , 2015 .

[2]  K. Hirakawa,et al.  Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer. , 2014, Hepato-gastroenterology.

[3]  I. Dogan,et al.  Albumin-globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[4]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[5]  K. Hirakawa,et al.  Prognostic value of preoperative inflammation-based prognostic scores in patients with stage IV colorectal cancer who undergo palliative resection of asymptomatic primary tumors. , 2013, Anticancer research.

[6]  Rana H. Bachir,et al.  Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients. , 2013, American journal of surgery.

[7]  K. Hirakawa,et al.  A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer. , 2013, Anticancer research.

[8]  Neeraj Shah,et al.  The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer , 2013, International Journal of Colorectal Disease.

[9]  D. McMillan,et al.  Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer , 2013, British Journal of Cancer.

[10]  K. Sakamoto,et al.  Glasgow Prognostic Score as a Prognostic Factor in Patients Undergoing Curative Surgery for Colorectal Cancer , 2013, Digestive Surgery.

[11]  R. Tang,et al.  Effect of preoperative neutrophil–lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy , 2011, International Journal of Colorectal Disease.

[12]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[13]  C. Bokemeyer,et al.  Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Nozoe,et al.  Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma , 2008, Surgery Today.

[15]  W. Scheithauer,et al.  Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  E. Livingston,et al.  Predictors of early mortality in veteran patients with pancreatic cancer. , 2007, American journal of surgery.

[17]  D. Lawlor,et al.  A systematic review of the association between circulating concentrations of C reactive protein and cancer , 2007, Journal of Epidemiology and Community Health.

[18]  J. Bauer,et al.  Malnutrition among gynaecological cancer patients , 2007, European Journal of Clinical Nutrition.

[19]  J. Carrillo,et al.  Serum Albumin as a Significant Prognostic Factor for Patients with Gastric Carcinoma , 2007, Annals of Surgical Oncology.

[20]  T. Boonpipattanapong,et al.  Preoperative Carcinoembryonic Antigen and Albumin in Predicting Survival in Patients With Colon and Rectal Carcinomas , 2006, Journal of clinical gastroenterology.

[21]  C. McArdle,et al.  A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer , 2005, British Journal of Cancer.

[22]  M. Chojkier.  Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. , 2005, Journal of clinical gastroenterology.

[23]  C. McArdle,et al.  Albumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients With Weight Loss , 2001, Nutrition and cancer.

[24]  C. Wilson,et al.  Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  R. James,et al.  Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial , 2000, The Lancet.

[26]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[27]  H. Hirai.  [CEA (carcinoembryonic antigen)]. , 1978, Nihon rinsho. Japanese journal of clinical medicine.

[28]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[29]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.